| atypical squamous cells of undetermined significance: human papillomavirus testing in adolescents. | to estimate the age-stratified prevalence of oncogenic human papillomavirus (hpv) infection and to evaluate risk factors for hpv acquisition among women with atypical squamous cells of undetermined significance (asc-us). | 2005 | 15802399 |
| atypical squamous cells of undetermined significance, human papillomavirus, and cervical intraepithelial neoplasia 2 or 3 in adolescents: asc-us, age, and high-grade cervical neoplasia. | to determine rates of and factors associated with cervical intraepithelial neoplasia (cin) 2 or 3 among women with atypical squamous cells of undetermined significance (asc-us) and oncogenic human papillomavirus (hpv) infection. | 2006 | 16829752 |
| national, state, and local area vaccination coverage among adolescents aged 13-17 years --- united states, 2009. | the advisory committee for immunization practices (acip) recommends that adolescents routinely receive the following vaccines: meningococcal conjugate (menacwy, 1 dose); tetanus, diphtheria, acellular pertussis (tdap, 1 dose); and (for females) human papillomavirus (hpv, 3 doses). adolescents also should receive the following recommended vaccinations they missed during childhood: measles, mumps, rubella (mmr, 2 doses); hepatitis b (hepb, 3 doses); and varicella (var, 2 doses). since 2006, cdc ha ... | 2010 | 20724968 |
| national and state vaccination coverage among adolescents aged 13 through 17 years--united states, 2010. | the advisory committee on immunization practices (acip) recommends that adolescents routinely receive meningococcal conjugate (menacwy, 2 doses); tetanus, diphtheria, acellular pertussis (tdap, 1 dose); and human papillomavirus (hpv, 3 doses) vaccines (influenza vaccine is recommended annually for all persons aged 6 months and older). cdc tracks vaccination coverage among adolescents aged 13 through 17 years through the national immunization survey--teen (nis-teen). to provide updated vaccinatio ... | 2011 | 21866084 |
| current initiatives to protect rhode island adolescents through increasing hpv vaccination. | this commentary provides an overview of recent initiatives in rhode island to promote human papillomavirus (hpv) vac-30 cination with the goal of protecting rhode island adolescents against vaccine-preventable hpv-associated cancers. with the exception of the introduction of a recent school entry requirement, most of the initiatives and related activities described were conducted as part of a cooperative agreement between 35 ridoh and cdc, and were supported by the prevention and public health f ... | 2016 | 27141954 |
| human papillomavirus (hpv) vaccination coverage among rhode island adolescents, 2008-2014. | | 2016 | 27128516 |